Alexandra Barlow
Nurse Practitioner · Houston, TXNPI 1003659103
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $34.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$730
- Johnson & Johnson$483
- Mallinckrodt Hospital Products Inc.$415
- AbbVie$384
- AstraZeneca$337
- Amgen$328
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,45999%
- Education$551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 18 | $730 |
| Johnson & Johnson | 8 | $483 |
| Mallinckrodt Hospital Products Inc. | 13 | $415 |
| AbbVie | 7 | $384 |
| AstraZeneca | 8 | $337 |
| Amgen | 13 | $328 |
| ANI Pharmaceuticals, Inc. | 12 | $225 |
| Pfizer | 7 | $187 |
| Lilly USA, LLC | 3 | $131 |
| Corcept Therapeutics | 1 | $113 |
| GSK | 6 | $108 |
| Axsome Therapeutics, Inc. | 1 | $98 |
| Fresenius Kabi USA, LLC | 4 | $97 |
| Vertex | 1 | $96 |
| Aurinia Pharma U.S., Inc. | 5 | $89 |
| Gilead | 1 | $87 |
| Novartis | 4 | $85 |
| Janssen Scientific Affairs, LLC | 1 | $85 |
| Eisai Inc. | 1 | $84 |
| Abiomed | 1 | $82 |
| Radius Health, Inc. | 2 | $53 |
| Organon | 6 | $52 |
| E.r. Squibb & Sons, L.L.C. | 2 | $44 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $40 |
| Genentech USA, Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,514 in reported general payments places this provider in the 90th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 51 | $1,504 |
| Gabapentin | 61 | $941 |
| MethotrexateMethotrexate Sodium | 42 | $729 |
| Celecoxib | 15 | $265 |
| Tizanidine Hcl | 36 | $258 |
| Duloxetine Hcl | 13 | $208 |
| Prednisone | 41 | $167 |
| Methylprednisolone | 16 | $152 |
| Meloxicam | 11 | $61 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Houston
- Melanie MorrisHouston$254K
- Julie WeatherlyHouston$87K
- Katrina KingHouston$44K
- Allison TurnerHouston$37K
- Tiffany RichardsHouston$37K
- Bianca CaloHouston$36K
- Arby CohenHouston$23K
- Virginia MarxHouston$19K
- Hermeyone BellHouston$17K
- Cecilia DavisAustin$262K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.